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Abstract
Background: Aging is associated with altered immune response, which increases susceptibility to infections.
sTREM-1 is involved in the amplification of the inflammatory response to bacterial infection. The present cross-
sectional study aims to investigate local sTREM-1 levels in gingival crevicular fluid (GCF) as well as key periodontal
pathogen levels in the subgingival plaque in an elderly cohort with periodontal health, gingivitis, and chronic
periodontitis (CP).
Methods: Subjects were 51 systemically healthy, elderly individuals (mean age, 68 ± 4.5 years) who had undergone
full-mouth periodontal examinations. Subgingival plaque and GCF samples were collected from the healthy sites of
participants without periodontal disease (n = 17), the sites with gingival inflammation from patients with gingivitis
(n = 19), and the periodontitis sites of patients with CP (n = 15). GCF volumes were measured by an electronic
impedance device, and total protein levels were assessed by a flouremetric assay. sTREM-1 levels in GCF were
measured by enzyme-linked immunosorbent assay. The subgingival plaque total bacteria, Porphyromonas gingivalis,
Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum, and Prevotella intermedia levels were determined
by quantitative real-time polymerase chain reaction. Statistical analysis was performed using nonparametric
methods.
Results: GCF volume, total protein concentrations, and sTREM-1 levels in GCF were similar among the groups
(p > 0.05). Significantly higher T. forsythia levels were observed in subgingival plaque samples harvested from
patients with gingivitis and CP, than in those from healthy participants (p < 0.05). However, the subgingival levels of
the other four periodontal pathogens and total bacteria were not statistically different among the groups (p > 0.05).
Conclusions: Our findings suggest that there are no differences in GCF volume, total protein, and sTREM-1 levels
between healthy and periodontally diseased elderly adults. We found only limited differences in the studied
subgingival microbial profile. This finding indicates an already deregulated, local inflammatory response in this
elderly cohort, on which bacterial biofilm challenge may have a limited further impact.
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Background
Periodontal diseases in their severe form affect approxi-
mately 10 % of the global population, and their direct treat-
ment poses a significant annual burden on national health
systems. They are characterized by localized inflammatory
destruction of periodontal tissues, occur as a result of sub-
gingival biofilm formation [1]. The host immune response
against the offending microorganisms is a key factor to sub-
sequent periodontal tissue destruction [2, 3]. Considerable
individual variation exists in microbial challenge and host
responses to periodontal bacteria [4–6], such as Porphyro-
monas gingivalis, Tannerella forsythia, and Treponema
denticola [7, 8]. Host-related factors, such as aging, can also
impair the periodontal host response [9].
The World Health Organisation defines an elderly per-
son as one who is 65 years and older [10]. Many physical
changes, such as reduction in bone mass, compromised
immune system, and cancer, occur with increasing age
[11]. Periodontal disease is one such change, as it is a
common chronic inflammatory disease among the eld-
erly [11]. The prevalence of mild to moderate periodon-
titis among the elderly is high [11, 12]. Inflammatory
mediator levels generally exhibit age-related changes,
even in the absence of acute infection or other physio-
logic stress [13]. A significant relationship exists between
aging, inflammation, response to infection, and progres-
sion of chronic, inflammatory diseases [14]. Although
periodontal disease is a common chronic, inflammatory
disease that occurs during an individual’s lifetime, its re-
lationship with aging has not been fully elucidated.
TREM-1, a receptor belonging to the immunoglobulin
superfamily, is produced and released during the course
of local and systemic infections, such as septic shock
and pneumonia [15–18]. To date, the role of TREM-1 in
innate immunity is postulated to be the regulation of the
inflammatory response magnitude to bacterial challenge,
which leads to increased proinflammatory cytokine pro-
duction [19, 20]. During infection, TREM-1 is released
from the cell surface as its soluble sTREM-1 form.
Because of this property, sTREM-1 has been proposed
as a biomarker of systemic inflammation in systemic
sepsis, arthritis, pulmonary infection, pancreatitis, and
inflammatory bowel disease [17, 18, 21–23].
A number of recent in vitro studies have shown that
P. gingivalis can stimulate TREM-1 production in
monocytes and neutrophils, promoting a shift from its
cell-membrane, bound form to sTREM-1, which is also
accompanied by propagation of proinflammatory cyto-
kine production [24–26]. We have shown in other stud-
ies that local and systemic sTREM-1 levels are elevated
in patients with periodontitis compared to healthy indi-
viduals [27, 28].
Nevertheless, the role of aging in periodontal inflam-
mation or the role of TREM-1 in elderly participants has
not been clearly established. It is worth noting that
TREM-1-induced polymorphonuclear neutrophil func-
tions, following TREM-1 engagement, exhibit an im-
paired response when obtained from elderly donors [28].
In line with this report, another study showed that
TREM-1 expression was elevated in macrophages ob-
tained from aged mice [29].
Hence, the hypothesis of the present study is that the
association between GCF sTREM-1 levels and periodon-
tal status, or subgingival microbiological parameters, is
impaired due to chronic exposure in an elderly popula-
tion. The null hypothesis is that age does not affect these
parameters in the gingival crevice or periodontal pocket.
Therefore, the aim of the present study was to assess
local sTREM-1 levels in GCF and key periodontal patho-
gen levels in the subgingival plaque of an elderly cohort
with periodontal health, gingivitis and CP.
Methods
Study population and clinical examination
This study includes 51 elderly individuals who were re-
cruited from the Department of Periodontology, School of
Dentistry, Ege University, Izmir, Turkey, between April
and September 2013. The study was approved by the
Ethics Committee of the Medical Faculty of Ege University
(ethics approval number: 11–12.1/11) and was conducted
according to the guidelines of the Declaration of Helsinki.
Written, informed consent was obtained from each of the
51 participants. Inclusion criteria included being: age 65
or older, systemically healthy, and non-smoker. Exclusion
criteria included: cardiovascular or respiratory diseases,
diabetes mellitus, HIV infection, immunosuppressive
chemotherapy, and current acute infection. None of the
participants had received antibiotics or other medications
or periodontal treatment within the past four-months.
All participants were evaluated clinically and radio-
graphically by a single, calibrated examiner experienced
in evaluating participants in clinical trials (VÖÖ). Full-
mouth clinical periodontal parameters were recorded,
including measurement of probing-pocket depth and
clinical attachment level at six sites around each tooth
with a manual probe [Williams probe]. Measurements in
third molars were excluded. Also recorded were PI [30]
and dichotomous measurement of BOP. Patient selec-
tion was conducted according to the criteria proposed
by the 1999 International World Workshop for a Classi-
fication of Periodontal Disease and Conditions [1]. Indi-
viduals of the control group had >15 teeth, no history of
periodontitis, no sites with >3 mm PPD, and >1 mm
CAL as well as no radiographic evidence of alveolar
bone loss. Patients of the gingivitis group exhibited no
sites with alveolar bone loss and had varying degrees of
gingival inflammation, but had no CAL >2 mm and full-
mouth BOP >50 %. Members of the periodontitis group
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had moderate to severe alveolar bone loss and at least
four nonadjacent teeth with sites of CAL of ≥6 mm, a
PPD ≥5 mm, and a full-mouth BOP >50 %.
Collection of GCF samples
After being selected for the study, participants were
recalled for GCF sampling with periopaper collection
strips (OraFlow Inc., Smithtown, NY, USA). The GCF
samples were collected from the two mesiobuccal aspects
of a single-rooted tooth with ≥5 mm probing depth with
BOP in the periodontitis group (n = 15, with mean PPD:
5.46 ± 0.51, CAL: 6.40 ± 0.98, PI: 2.52 ± 0.20), while 2 GCF
samples were collected from two mesiobuccal aspects of a
single-rooted tooth with probing depth up to 3 mm with
BOP in the gingivitis group (n = 19, with mean PPD: 2.68
± 0.47, CAL: 2.68 ± 0.56, PI: 2.57 ± 0.50). In the healthy
group two GCF samples were collected from the
mesiobuccal aspect of single-rooted teeth exhibiting
probing-pocket depth up to 3 mm without BOP (n = 17,
with mean PPD: 2.00 ± 0.61, CAL: 2.00 ± 0.61, PI: 0.17 ±
0.39). The volume of GCF absorbed in each strip (OraFlow
Inc. Smithtown, NY, USA) was determined by electronic
impedance (Periotron 8000; Proflow, Inc., Amityville, NY,
USA). Immediately afterwards, the collected paper strips
were directly placed into microcentrifuge tubes and stored
at 80 °C until needed for laboratory analysis.
Determination of total protein concentrations in GCF
samples
On the day of analysis, the GCF samples were eluted in
420 μL of phosphate-buffered saline (pH 7.2), containing
EDTA-free Protease Inhibitor Cocktail (Roche Applied
Science, Basel, Switzerland) by centrifugation at 5000 × g
for 10 min at 4 °C. The total protein content of GCF
was quantified with the Qubit Protein Assay Kit
(Thermo Fisher Scientific, Zug, Switzerland) according
to manufacturer’s instructions. Briefly, 3 assay tubes
were prepared for standards and one assay tube per
sample. Qubit working solution was prepared by diluting
the Qubit reagent in buffer. Then 10 μL sample or
standard were added to assay tubes, which were incu-
bated for 15 min at room temperature. Samples were in-
cubated for 15 min. Then, the tubes were read in the
Qubit® 2.0 Flourometer (Thermo Fisher Scientific, Zug,
Switzerland).
Determination of sTREM-1 in GCF samples
sTREM-1 levels in GCF were measured using an ELISA
kit (DuoSet, R&D Systems, Abingdon, UK) according to
manufacturer‘s instructions with some modifications.
Briefly, 100 μL of standards or test samples were added
to microplates in duplicate, incubated for 2 h at room
temperature, followed by removal of the liquid from
each well. A biotin-conjugated antibody specific for
sTREM-1 and avidin conjugated to horseradish peroxid-
ase was added to each well, incubated for 2 h at room
temperature, and the unbound antibody was removed by
washing in PBS twice for 2 min on a stirring plate. Then,
tetramethylbenzidine was added as a substrate solution
to each well and incubated for 20 min at room
temperature, after which the reaction was stopped by
the addition of 1 M sulfuric acid solution. The absorb-
ance was measured at 450 nm using a microplate reader
(Epoch, BioTek, Luzern, Switzerland), with a wavelength
correction set at 570 nm to subtract background. The
concentration of sTREM-1 in the samples was then de-
termined by comparing the absorbance of the samples
with the standard curve generated by the measurement
of the concentrations of recombinant human sTREM-1.
The results were presented in two ways: (i) dividing total
amount of sTREM-1 recovered in 420 μL PBS by the
volume of the sample as measured by Periotron, and
expressed as pg/μL) and (ii) calibrating against total pro-
tein amount, as measured by a fluorometric assay and
expressed as pg/mg protein.
Collection and processing of subgingival plaque samples
Approximately 15 min after GCF collection, subgingival
plaque samples were collected from the four mesiobuc-
cal surfaces of the preselected, single-rooted teeth using
two standardized ♯ 30 sterile paper points. One point
was inserted at a 45° angle and the other parallel to the
long axis of the tooth and left place for 10 s. The paper
points were then frozen at −70 ° C until further use.
Subgingival plaque samples were collected from the
mesiobuccal surface aspects of a single-rooted tooth
with ≥5 mm probing depth with BOP in the CP group
(n = 15, with mean PPD: 5.65 ± 0.40, CAL: 6.07 ± 0.32,
PI: 2.40 ± 0.25), while the other samples were collected
the from 4 mesiobuccal surfaces of a single-rooted tooth
with probing depth up to 3 mm with BOP in the gingi-
vitis group (n = 19, with mean PPD: 2.52 ± 0.56, CAL:
2.52 ± 0.56, PI: 2.45 ± 0.50). In the healthy group, the
samples were collected from the mesiobuccal aspect of
single-rooted teeth exhibiting probing-pocket depth up to
3 mm without BOP (n = 17, with mean PPD: 2.10 ± 0.42,
CAL: 2.10 ± 0.42, PI: 0.16 ± 0.22). For DNA extraction, the
collected subgingival plaque samples were processed using
a commercially available kit (GenElute Bacterial Genomic
DNA Kit, Sigma-Aldrich, Buchs, Switzerland), and the
concentration of resulting DNA was measured spectro-
photometrically (NanoDrop 1000, Thermo Fisher Scien-
tific, Wohlen, Switzerland).
Bacterial quantification by qPCR
Selected putative, periodontal pathogens and total bacterial
load in the subgingival plaque were detected as described
earlier [31]. Briefly, DNA amplification and detection were
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performed in a qPCR system (StepOnePlus, Applied
Biosystems Life Technologies, Basel, Switzerland), using
master mix SYBR Green Master Mix (Applied Biosystems
Life Technologies, Basel, Switzerland) for the amplification
reaction. Each reaction was performed in a total of 20 μL,
including the species-specific oligonucleotide primers and
10 ng DNA extracted from subgingival plaque samples, ac-
cording to manufacturer’s guidelines as described earlier
[27]. Bacterial DNA of known amounts (1.0–0.0001 ng)
was extracted from pure cultures of the taxa under investi-
gation for the purpose of generating standard curves to es-
timate number of copies of each species in the subgingival
plaque. Briefly, P. gingivalis (ATCC 33277 T; OMZ 925)
was grown anaerobically on Columbia Blood Agar (CBA)
agar plates for 3–4 days at 37 °C, followed by anaerobic
subculturing for 2–3 days at 37 °C in broth. T. forsythia
(OMZ 1047), T. denticola (ATCC 35405; OMZ 661), P.
intermedia (OMZ 278), F. nucleatum (OMZ 598), were
maintained in liquid cultures as described earlier [32]. DNA
was extracted from these cultures and measured as
indicated above. The lowest detection limits for the qPCR
assays were defined by the cycle, threshold signal corre-
sponding to the lowest DNA amount used for generating
the standard curve (0.0001 ng). The theoretical bacterial
numbers in each sample were calculated on the basis of
measured amount of DNA and the estimated genome
weight as described earlier [31].
Statistical analyses
Statistical analyses were conducted using a statistical
software package (GraphPad Software, La Jolla California
USA). The minimum sample size was calculated in healthy
and diseased groups by accepting a power of 90 % and a P-
value of 5 %. A power calculation suggested that the mini-
mum sample size required was 13 participants for each
group. Distribution of data was evaluated by the normality
test. Comparisons among the non-normally-distributed var-
iables, such as GCF sTREM-1 and subgingival bacterial
levels, were performed by the Kruskal–Wallis one-way
ANOVA and Dunn’s test. Clinical parameters and demo-
graphic data were normally distributed and assessed by
ANOVA. P < 0.05 was considered statistically significant.
Results
Clinical findings
Demographic data and full-mouth clinical findings are
provided in Table 1. Age and gender were similar among
groups. Full-mouth mean PPD, CAL, PI, and BOP scores
were significantly higher in the CP and gingivitis groups
than in the healthy group (P < 0.0001) (Table 1). In con-
trast, the number of existing teeth was similar among
groups.
Microbiological findings in subgingival plaque
Subgingival plaque samples were assessed by qPCR for
five individual species and total bacterial counts. Fre-
quencies of detection of species and bacterial counts are
shown in Table 2. There were no differences in total
bacterial levels among the three groups, with mean
counts in the health group: 2.4 × 109 ± 5.0 × 109, in the
gingivitis group: 2.8 × 109 ± 3.3 × 109, and in the CP
group: 7.2 × 109 ± 7.7 × 109 (P > 0.05) (Fig. 1a). P.
gingivalis, T. denticola, F. nucleatum, and P. intermedia
Table 1 Full-mouth clinical findings of the study groups (n = 51)
Clinical Parameters Healthy Group
(n = 17)
Gingivitis
Group (n = 19)
Chronic Periodontitis
Group (n = 15)
Gender 7 F-10 M 8 F-11 M 9 F-6 M
Age 68.53 ± 4.57 68.47 ± 5.52 68.40 ± 3.13
Probing-pocket depth (mm) 1.97 ± 0.31 2.80 ± 0.18* 4.66 ± 0.22**
Clinical attachment level (mm) 1.98 ± 0.30 2.81 ± 0.18* 5.23 ± 0.31**
Plaque index 1.12 ± 0.32 2.29 ± 0.23* 2.52 ± 0.20*
Bleeding on probing (%) 1.29 ± 3.67 51.42 ± 13.06* 70.27 ± 11.20*
Number of teeth 24.17 ± 2.85 21.68 ± 1.91 21.93 ± 1.90
Number of single-rooted teeth 18.24 ± 2.33 17.53 ± 1.80 16.60 ± 1.76
The values represent the mean ± standard deviation (SD) of the studied clinical parameters
F: Female; M: Male
*Significant differences from the healthy group (p < 0.05)
**Significant differences from the healthy and gingivitis groups (p < 0.05)
Table 2 Detection of periodontal pathogens in subgingival
plaque of the elderly in healthy and diseased groups (n = 51)




n 17 19 15
F. nucleatum n (%) 8 (47) 12 (63) 8 (53)
P. intermedia n (%) 4 (23) 9 (47) 7 (46)
P. gingivalis n (%) 1 (5) 7 (36) 6 (40)
T. denticola n (%) 3 (17) 7 (36) 6 (40)
T. forsythia n (%) 1 (5) 7 (36) 7 (46)
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Fig. 1 (See legend on next page.)
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in the subgingival plaque were also similar among the
three groups (P >0.05) (Fig. 1b, c, d, and e). T. forsythia
levels in the subgingival plaque were significantly higher
in the CP group (by 6.5 × 105-fold) and gingivitis group
(by 6.4 × 103-fold) than in the healthy group (p < 0.05)
(Fig. 1f ).
Analysis of GCF volume and total protein analysis
The mean ± SEM value of GCF volume was 0.36 ± 0.26 μL
in the healthy group, 0.41 ± 0.17 μL in the gingivitis group,
and 0.49 ± 0.22 μL in the CP group (Fig. 2a). The volume
of the collected GCF samples was not significantly differ-
ent between the three groups (P > 0.05). In a similar man-
ner, although the CP group had a 1.4-fold higher total
protein content than the healthy group, that difference did
not reach significance (P > 0.05) The mean ± SEM values
were in the healthy group: 303.7 ± 105.30 mg/mL, gingivitis
group: 370.26 ± 263.97 mg/mL, and CP group: 448 ± 93.18)
(Fig. 2b).
Analysis of sTREM-1 Levels in GCF
Concentrations of sTREM-1 in GCF were expressed as
total amounts (pg) (Fig. 3a) or pg/μL after normalizing
total amounts to GCF volume (Fig. 3b) or as pg/mg of
protein after normalization of the ELISA read-outs to total
protein levels. sTREM-1 was not detected in three of 17
healthy participants and 1 of 19 gingivitis patients.
sTREM-1 amounts in GCF (mean ± SEM) were 25.86 ±
9.27 pg in the healthy sites, 33.43 ± 6.39 pg in the gingivitis
sites, and 40.56 ± 8.71 pg in the CP sites. However, none
of the differences among the 3 groups were significant.
Additionally, sTREM-1 concentrations either normalized
by GCF volume (mean ± SEM, healthy group: 144 ±
54.00 pg/μL, gingivitis group: 85.05 ± 15.24 pg/μL, and CP
group: 106.3 ± 24.40 pg/μL) or by total protein content
did not significantly differ among the groups. The result-
ing sTREM-1 concentrations were calculated by dividing
sTREM-1 amount values by volume of each GCF sample
individually. However, none of the differences among any
of the groups proved to be statistically significant.
(See figure on previous page.)
Fig. 1 Oral microbiota levels in the subgingival plaque from elderly individuals with periodontal health (n = 17), gingivitis (n = 19), and chronic
periodontitis (n = 15). The individual values represent bacterial counts per sample in the subgingival plaque (a) Total bacterial counts, (b) F. nucleatum,
(c) P. intermedia, (d) P. gingivalis, (e) T. denticola, and (f) T. forsythia. The horizontal lines in the middle of the box represent the median and whiskers are
drawn down to the 10th through 90th percentiles. The points below and above the whiskers are drawn as individual dots
Fig. 2 The inflammatory characteristics of the GCF samples from elderly patients with or without periodontal disease. GCF volume (a) was
measured using a calibrated Periotron 8000, and then the readings were converted to an actual volume (μL) by reference to the standard curve.
GCF total protein concentrations (b) were measured with a fluorometric assay. Horizontal lines show median values
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Discussion
Aging can alter immune cell functions that can greatly in-
fluence bacterial clearance and wound healing in any given
site [33, 34], thus contributing to an increase in the occur-
rence of infections, including periodontitis, in the elderly
population. Although prevalence of periodontal disease
increases with age, the underlying factors for the increase
remain unclear. The present cross-sectional study evaluated
the levels of sTREM-1, an amplifier of inflammation [35],
in GCF of elderly patients with gingivitis and CP and in in-
dividuals with clinically healthy periodontium. Recently,
one study showed that patients with periodontitis have
Fig. 3 Distribution of sTREM-1 levels in GCF from healthy sites (n = 17), gingivitis-affected sites (n = 19), and periodontitis-affected sites of patients
with CP (n = 15). sTREM-1 levels in the GCF samples were determined by ELISA. Individual values represent sTREM-1 as pg/mg of protein after
normalization of the ELISA read-outs to total protein levels (a), sTREM-1 total amounts (pg) (b), or sTREM-1 concentrations (pg/μL) calibrated against
corresponding GCF volume (c). Horizontal lines indicate the median values
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elevated sTREM-1 levels in the saliva and serum [36] or in
the GCF, and that sTREM-1 levels increase with the sever-
ity of the disease [27, 37]. Additionally, sTREM-1 levels
were positively associated with the presence of putative,
periodontal pathogens present in the corresponding
subgingival plaque samples [27]. To the best of our
knowledge, the present study is the first to provide data
on GCF of sTREM-1 in patients with CP and gingivitis
and in systemically healthy elderly individuals. Interest-
ingly, GCF sTREM-1 levels in elderly patients with CP
and gingivitis were comparable with those in periodon-
tally healthy individuals, as there were no differences
among the groups. The lack of a statistically significant
difference could potentially be explained by the aging
process itself. In other terms, by a potential loss of the
capacity of aged gingival tissue to respond to microbial
challenge in a pathophysiologic fashion [38]. In support
of this finding hinting for a reduced response of aged
gingival tissues to microbial challenge, earlier studies
showed that a number of monocyte/macrophage func-
tions become compromised with age, including chemo-
taxis, phagocytosis, production of reactive oxygen
species, and induction of certain cytokine responses [39,
40]. The effects of aging on periodontal tissues may be
reflected as biomolecular changes in the periodontium.
Indeed, LPS-induced cytokine responses were found to
decline with age [41]. Fortin et al. showed that al-
tered TREM-1 signaling in aged neutrophils was ex-
plained by defective recruitment of TREM-1 to lipid
rafts [28], which may lead to altered shedding of
sTREM-1 in the elderly. Therefore, the similar sTREM-
1 levels seen among clinical groups in the present eld-
erly population are likely to be related to these
phenomena.
Less is known about the relationship of sTREM-1 and
periodontal pathogens. In vitro studies have shown that P.
gingivalis induces TREM-1 production in monocytes and
secretion of TREM-1 in its soluble form [24, 26, 29]. In
contrast, it was recently demonstrated in a mouse study
that host immune responses to P. gingivalis, including
TREM-1 expression, are reduced by age [42]. Another ex-
planation could be that differences in dietary habits, in-
creased flow of GCF by inflamed gingiva, and possible
age-related changes in salivary gland secretions may simi-
larly alter the conditions for growth and multiplication of
the plaque-associated bacteria [43, 44]. Hence, the low dif-
ferences in bacterial populations, with the exception of T.
forsythia, at a given site may result in a similar inflamma-
tory profile, including sTREM-1, between the healthy and
diseased groups observed here.
The potential limitation of this study is that it is cross-
sectional in nature, and thus does not allow for the
continuous monitoring of the studied inflammatory me-
diator over time in this patient cohort. Future studies
could address a similar question on sTREM-1 in a pro-
spective manner, monitoring patients of different ages
and over longer periods of time.
Conclusions
The present study demonstrates that in the instance of
periodontal disease, GCF sTREM levels are not elevated
in the elderly population, and that only limited differ-
ences exist in their studied subgingival microbial pro-
files. Hence, these findings are in line with the notion
that the severity of periodontitis in older age could result
simply from the cumulative inflammatory effect of pro-
longed exposure to microbial challenge [45].
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